Revascularization for peripheral artery disease (angioplasty, stenting, bypass)
Revascularization is the group of procedures, open surgery or endovascular treatment, used on narrowed or blocked arteries in peripheral artery disease. Reviews describe bypass surgery and endovascular treatment (procedures done from inside the blood vessels) as the mainstream treatments. One review of endovascular options calls percutaneous transluminal angioplasty one of the mainstays of endovascular therapy and says stents have evolved to include bare metal, covered and drug-eluting types. The reviews also say the best choice between surgical and endovascular approaches is still debated, and one says not all people with chronic limb-threatening ischemia are suitable for revascularization.
Also called Peripheral artery revascularization · Endovascular treatment of peripheral artery disease · Bypass surgery for peripheral artery disease · Percutaneous transluminal angioplasty (PTA)
- Intervention
- In this atlas
Overview
Technical summary
MeSH Endovascular Procedures (D057510, broad): its scope note describes minimally invasive procedures done within the blood vessels, which is wider than peripheral artery treatment; the scope note does not mention bypass surgery. The record rests on that scope note and on three open-access reviews (PMC10095037, PMC12786405 and PMC7043107, all CC BY 4.0). The reviews' trial results, pooled effect estimates, device results and conclusions in favour of one approach are not repeated here, and the atlas states no recommendation of when to use either approach. Strategy page; the evidence recorded is descriptive and comes from reviews, with no study data of its own.
About this intervention
- Type
- Procedure
- Mechanism
- Bypass surgery is an operation. Endovascular treatment is done within the blood vessels and includes angioplasty and stents (reviews; MeSH defines endovascular procedures as minimally invasive procedures performed within the blood vessels).
Classification codes
-
D057510
Claims and evidence
Context People with peripheral artery disease, including limb-threatening disease (MeSH scope note and three reviews)
- Recipient
- Recipient not specified
- Population
- People with peripheral artery disease considered for treatment of blocked leg arteries, as the MeSH scope note and the reviews describe them. One review is about chronic limb-threatening ischemia and another about disease below the groin (infrainguinal); neither is a single study population.
- Care setting
- Vascular surgery and endovascular treatment, as the reviews describe them.
- Geography
- Not stated for the reviews as a whole.
- Life stage
- Adults are implied but not stated. This record makes no statement about pregnancy, newborns or children.
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (reviews of treatment approaches; follow-up periods of individual studies are not recorded).
Eligibility: 1 inclusion criterion; exclusion criteria not stated
- Included
- Peripheral artery disease treated with surgery or endovascular procedures
- Excluded
- None stated
MeSH describes endovascular procedures as minimally invasive procedures performed within the blood vessels. A 2025 systematic review (Journal of Clinical Medicine) calls bypass surgery and endovascular treatment the mainstream treatments for peripheral artery disease and says the choice of treatment varies and the best approach has been a subject of ongoing controversy; it also says guidelines widely recommend endovascular therapy for infrainguinal disease despite a lack of adequately powered data. A 2020 review (F1000Research) describes percutaneous transluminal angioplasty as one of the mainstays of endovascular therapy and says stents have evolved to include bare metal, covered and drug-eluting types. A 2023 review of chronic limb-threatening ischemia says there is still a lack of consensus on the best treatment strategy and that not all patients are suitable for revascularization.
Applies to Recipient not specified People with peripheral artery disease, including limb-threatening disease (MeSH scope note and three reviews)
- Certainty method
- Not assessed
- Limitations
- Reviews that describe approaches and their debate. Pooled effect estimates, trial results, device results and each review's own conclusion about which approach to prefer are not repeated and not assessed, and the atlas makes no recommendation. The sources do not define bypass surgery beyond naming it, and they cover different parts of the leg arteries.
- Last checked
- 2026-11-18
- Next evidence check due
- Not scheduled
Sources and citations (8)
-
Background Chronic Limb-Threatening Ischemia and the Need for Revascularization
- Locator
- Abstract, Background, sentence 4
- How it applies
- In chronic limb-threatening ischemia the review says there is still a lack of consensus on the best treatment strategy.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
1bf40be5eee462217350ea27e088333d0294ff4fdbe1136b6cffc5edd8f9f7bb- Reuse basis
- PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
-
Supports Chronic Limb-Threatening Ischemia and the Need for Revascularization
- Locator
- Abstract, Results, sentence 2 (part)
- How it applies
- The review says not all patients with chronic limb-threatening ischemia are suitable for revascularization.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
1bf40be5eee462217350ea27e088333d0294ff4fdbe1136b6cffc5edd8f9f7bb- Reuse basis
- PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
-
Supports MeSH scope note for descriptor D057510 (Endovascular Procedures)
- Locator
- scopeNote.@value, sentence 1
- How it applies
- MeSH: endovascular procedures are minimally invasive procedures performed within the blood vessels.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
3237ee241ca87299b9cc6f99d562e52f5e731dd23f37dbdaf183f420a0f6fc54- Reuse basis
- The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, fetched 2026-11-08, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-08 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
-
- Locator
- 1. Introduction, para 2, sentence 1
- How it applies
- The review calls bypass surgery and endovascular treatment the mainstream treatments for peripheral artery disease.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
2519b30bd3e1e1c6be8bcabb1a5db6c8414a1fd8fdf07ce8b1ae40bc086b1d2f- Reuse basis
- PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
-
- Locator
- 1. Introduction, para 2, sentence 2 (part)
- How it applies
- The review says the choice of treatment varies and the best approach has been a subject of ongoing controversy.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
2519b30bd3e1e1c6be8bcabb1a5db6c8414a1fd8fdf07ce8b1ae40bc086b1d2f- Reuse basis
- PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
-
- Locator
- Abstract, Objectives, sentence 1
- How it applies
- The review says guidelines widely recommend endovascular therapy for infrainguinal disease despite a lack of adequately powered data.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
2519b30bd3e1e1c6be8bcabb1a5db6c8414a1fd8fdf07ce8b1ae40bc086b1d2f- Reuse basis
- PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
-
Supports Recent advances in endovascular treatment of peripheral arterial disease
- Locator
- Percutaneous transluminal angioplasty, para 1, sentence 1 (end)
- How it applies
- Percutaneous transluminal angioplasty is described as one of the mainstays of endovascular therapy.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
fd265bf6666ee2c3b49cbbd613b6fb9cf135f1fc472ba2fd5ed9c2d43efe6b49- Reuse basis
- PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
-
Supports Recent advances in endovascular treatment of peripheral arterial disease
- Locator
- Endovascular stents, para 1, sentence 2
- How it applies
- Stents have evolved to include bare metal stents, covered stents and drug-eluting stents.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
fd265bf6666ee2c3b49cbbd613b6fb9cf135f1fc472ba2fd5ed9c2d43efe6b49- Reuse basis
- PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
Clinical links
Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.
-
Claim, not a settled fact Reviews describe bypass surgery and endovascular treatment as the mainstream treatments for peripheral artery disease; the best approach is debated: Peripheral artery disease
Applies to Recipient not specified People with peripheral artery disease, including limb-threatening disease (MeSH scope note and three reviews)
MeSH describes endovascular procedures as minimally invasive procedures performed within the blood vessels. A 2025 systematic review (Journal of Clinical Medicine) calls bypass surgery and endovascular treatment the mainstream treatments for peripheral artery disease and says the choice of treatment varies and the best approach has been a subject of ongoing controversy; it also says guidelines widely recommend endovascular therapy for infrainguinal disease despite a lack of adequately powered data. A 2020 review (F1000Research) describes percutaneous transluminal angioplasty as one of the mainstays of endovascular therapy and says stents have evolved to include bare metal, covered and drug-eluting types. A 2023 review of chronic limb-threatening ischemia says there is still a lack of consensus on the best treatment strategy and that not all patients are suitable for revascularization.Limitations. Reviews that describe approaches and their debate. Pooled effect estimates, trial results, device results and each review's own conclusion about which approach to prefer are not repeated and not assessed, and the atlas makes no recommendation. The sources do not define bypass surgery beyond naming it, and they cover different parts of the leg arteries.
-
Claim, not a settled fact A review of chronic limb-threatening ischemia discusses revascularization and says not all patients are suitable for it: Chronic limb-threatening ischemia
Applies to Recipient not specified People with peripheral artery disease, including limb-threatening disease (MeSH scope note and three reviews)
MeSH describes endovascular procedures as minimally invasive procedures performed within the blood vessels. A 2025 systematic review (Journal of Clinical Medicine) calls bypass surgery and endovascular treatment the mainstream treatments for peripheral artery disease and says the choice of treatment varies and the best approach has been a subject of ongoing controversy; it also says guidelines widely recommend endovascular therapy for infrainguinal disease despite a lack of adequately powered data. A 2020 review (F1000Research) describes percutaneous transluminal angioplasty as one of the mainstays of endovascular therapy and says stents have evolved to include bare metal, covered and drug-eluting types. A 2023 review of chronic limb-threatening ischemia says there is still a lack of consensus on the best treatment strategy and that not all patients are suitable for revascularization.Limitations. Reviews that describe approaches and their debate. Pooled effect estimates, trial results, device results and each review's own conclusion about which approach to prefer are not repeated and not assessed, and the atlas makes no recommendation. The sources do not define bypass surgery beyond naming it, and they cover different parts of the leg arteries.
Record details
- Record id
cardio:revascularization-for-peripheral-artery-disease-angioplasty-stenting-bypass- Content hash
63115c116197cd6d66922008f9e5f11b0d7c2c0469861b80834f12479341ea47